DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Mirtazapine is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Impax Labs Inc, Zydus Pharms, Apotex Inc, Aurobindo, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Roxane, Sun Pharm Inds Inc, Teva, Upsher Smith Labs, and Watson Labs. and is included in twenty NDAs.
The generic ingredient in MIRTAZAPINE is mirtazapine. There are eighteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the mirtazapine profile page.
A generic version of MIRTAZAPINE was approved as mirtazapine by TEVA on January 24th, 2003.
Summary for MIRTAZAPINE
|Finished Product Suppliers / Packagers:||30|
|Raw Ingredient (Bulk) Api Vendors:||135|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for MIRTAZAPINE|
|Drug Sales Revenues:||Drug sales revenues for MIRTAZAPINE|
|What excipients (inactive ingredients) are in MIRTAZAPINE?||MIRTAZAPINE excipients list|
|DailyMed Link:||MIRTAZAPINE at DailyMed|
Recent Clinical Trials for MIRTAZAPINE
Identify potential brand extensions & 505(b)(2) entrants
|St. Anna Ziekenhuis, Geldrop, Netherlands||N/A|
|Hospices Civils de Lyon||Phase 3|
|University of California, Los Angeles||Phase 1|